Keudell/Morrison Wealth Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Keudell/Morrison Wealth Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6,700	Closed	-$346K	–	195
2022 Q3	$346K	Buy	+6,700	New	+$277K	0.13%	118
2022 Q1	–	Sell	-7,200	Closed	-$262K	–	201
2021 Q4	$262K	Buy	+7,200	New	+$253K	0.1%	155

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Keudell/Morrison Wealth Management's CCXI Position: Q4 2022 in Review

Keudell/Morrison Wealth Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 6,700 shares — an estimated $346K sold.

Keudell/Morrison Wealth Management first reported a position in CCXI in Q4 2021 and held it in 2 quarters. The position peaked at $346K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Keudell/Morrison Wealth Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Keudell/Morrison Wealth Management sold 6,700 ChemoCentryx, Inc. shares in Q4 2022, an estimated $346K.
Keudell/Morrison Wealth Management first reported a position in ChemoCentryx, Inc. in Q4 2021 and held it in 2 quarters.
Keudell/Morrison Wealth Management's ChemoCentryx, Inc. position peaked at $346K in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Keudell/Morrison Wealth Management's 13F filing for Q4 2022, filed 20 Jan 2023.